Please ensure Javascript is enabled for purposes of website accessibility

Cronos Group Commits to Releasing Q4 Results in March

By Eric Volkman - Mar 2, 2020 at 6:21PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company also provided an explanation as to why it's delayed reporting.

Cronos Group's (CRON 1.42%) fourth-quarter and full-year results for fiscal 2019 might be coming any day now, if a new set of regulatory filings is anything to go by.

In the filings with the Securities and Exchange Commission (SEC) submitted on Monday, Cronos said it was tacking on a 15-day extension to its filing deadline, as per federal securities law. It added that it plans to release the quarterly and annual figures "promptly."

"However," it warned, "no assurance can be given that the Company will be able to meet the extended filing deadline."

Wilted marijuana plants.

Image source: Getty Images.

Among Cronos' new SEC filings was a 10-K, the requisite annual report. But significant sections of this document have been omitted. 

In an accompanying document, the company said the reason for its reporting delay, and by extension the omissions, is that it

has been unable to complete its financial statements for fiscal 2019 due to a continuing review by the Audit Committee of the Company's Board of Directors, with the assistance of outside counsel and forensic accountants, of several bulk resin purchases and sales of products through the wholesale channel and the appropriateness of the recognition of revenue from those transactions.

Cronos was originally slated to publish its quarterly and annual results on Feb. 27. At that time, it provided neither a time frame for the release, nor an explanation for the delay.

Investors will be hoping that the company's latest quarter is an improvement over its third-quarter results, which featured a miss on the top line and a net profit due almost entirely to a one-time accounting gain.

On Monday, a good day for equities generally, shares of the marijuana stock ended the day almost 3% higher. 


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cronos Group Stock Quote
Cronos Group
$2.86 (1.42%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.